Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

WHWK holding history

Whitehawk Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WHWK overviewAll 13F holders of WHWKFull Q2 2026 holdings

Shares (Q2 2026)
50,841
Value
$232.9K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of WHWK by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202650,841$232.9K<0.1%+39,403+344.5%AddedHolders
Q1 202611,438$39.5K<0.1%−18,406−61.7%ReducedHolders
Q4 202529,844$72.2K<0.1%+24,151+424.2%AddedHolders
Q3 20255,693$10.8K<0.1%−2,980−34.4%ReducedHolders
Q2 20258,673$16.2K<0.1%−26,894−75.6%ReducedHolders
Q1 202535,567$63.3K<0.1%−23,607−39.9%ReducedHolders
Q4 202459,174$186.7K<0.1%+8,467+16.7%AddedHolders
Q3 202450,707$104.5K<0.1%−19,658−27.9%ReducedHolders
Q2 202470,365$102.7K<0.1%+49,654+239.7%AddedHolders
Q1 202420,711$48.5K<0.1%+2,951+16.6%AddedHolders
Q4 202317,760$35.9K<0.1%+8,634+94.6%AddedHolders
Q3 20239,126$44.2K<0.1%−139−1.5%ReducedHolders
Q2 20239,265$63.4K<0.1%+2,841+44.2%AddedHolders
Q1 20236,424$46.5K<0.1%+1,399+27.8%AddedHolders
Q4 20225,025$64.5K<0.1%+5,025NewHolders
Q3 20220$00.0%−16,434−100.0%Sold outHolders
Q2 202216,434$202.0K<0.1%−40,250−71.0%ReducedHolders
Q1 202256,684$961.0K<0.1%+32,590+135.3%AddedHolders
Q4 202124,094$581.0K<0.1%+23,854+9,939.2%AddedHolders
Q3 2021240$7.00K<0.1%+227+1,691.0%AddedConverted for a 1-for-15 splitHolders
Q2 2021201$00.0%−2,965−93.7%ReducedHolders
Q1 20213,166$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.